![Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two](https://onlinelibrary.wiley.com/cms/asset/486de86d-d03f-4590-b6d2-2cd1ad464a37/bjd17791-fig-0003-m.jpg)
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two
![An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period | JCAD | The Journal of An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period | JCAD | The Journal of](https://bwcbuildout.com/jcad/wp-content/uploads/DelRossoNov2019Table1.gif)
An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period | JCAD | The Journal of
Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysis
Acne Vulgaris: The Majority of Patients Do Not Achieve Success According to FDA Guidance - JDDonline - Journal of Drugs in Dermatology
![A) Evaluation of Investigator's Global Assessment Scale (IGA), Prurigo... | Download Scientific Diagram A) Evaluation of Investigator's Global Assessment Scale (IGA), Prurigo... | Download Scientific Diagram](https://www.researchgate.net/publication/361355011/figure/fig1/AS:11431281173773153@1689025235855/A-Evaluation-of-Investigators-Global-Assessment-Scale-IGA-Prurigo-Activity-Score.png)
A) Evaluation of Investigator's Global Assessment Scale (IGA), Prurigo... | Download Scientific Diagram
![Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel | JCAD | The Journal of Clinical and Aesthetic Dermatology Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/August2018DelRossoTable1.gif)
Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel | JCAD | The Journal of Clinical and Aesthetic Dermatology
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel
![Rosacea. Investigator's Global Assessment (IGA) score assessed at week... | Download Scientific Diagram Rosacea. Investigator's Global Assessment (IGA) score assessed at week... | Download Scientific Diagram](https://www.researchgate.net/publication/333449920/figure/fig3/AS:869790134566912@1584385536012/Rosacea-Investigators-Global-Assessment-IGA-score-assessed-at-week-12.png)
Rosacea. Investigator's Global Assessment (IGA) score assessed at week... | Download Scientific Diagram
Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety - JDDonline - Journal of Drugs in Dermatology
![Proportion of patients achieving an Investigator's Global Assessment... | Download Scientific Diagram Proportion of patients achieving an Investigator's Global Assessment... | Download Scientific Diagram](https://www.researchgate.net/publication/319981401/figure/fig2/AS:572953210830848@1513614098378/Proportion-of-patients-achieving-an-Investigators-Global-Assessment-IGA-score-of-0-1.png)